Clinical Trials Browser

Phase 2 × Tretinoin × 90 days × Clear all

NCT05345002 2026-02-20

All-Trans Retinoic Acid (ATRA) Plus PD-1 Inhibition in Recurrent IDH-Mutant Glioma

Phase 2 Recruiting

Astrocytoma, Glioma, Oligodendroglioma

NCT06358677 2026-02-13

FACE

Phase 2 Recruiting

Neoplasm Metastasis

NCT04241276 2026-01-07

STARPAC2

Phase 2 Active not recruiting

Gastrointestinal

Pancreatic Neoplasms